| 1 |
ASSOCIATION OF INTERLEUKIN 1 RECEPTOR TYPE 1 POLYMORPHISM RS956730 WITH VITILIGO SUSCEPTIBILITY IN ASSIUT UNIVERSITY HOSPITALS. |
2025 |
| 2 |
Direct-acting antiviral treatment significantly shaped the gut microbiota in chronic hepatitis C patients: a pilot study |
2025 |
| 3 |
Genome Characterization of Carbapenem-Resistant Hypervirulent Klebsiella pneumoniae Strains, Carrying Hybrid Resistance-Virulence IncHI1B/FIB Plasmids, Isolated from an Egyptian Pediatric ICU |
2025 |
| 4 |
Imbalance of Follicular Double Positive and Follicular Double Negative T cells in Ulcerative Colitis Patients |
2025 |
| 5 |
UBASH3A and TIGIT Genes Expression Levels in Systemic Sclerosis |
2025 |
| 6 |
A study on COVID-19 patients in a period from January 2022 to August 2022 in Assiut city |
2024 |
| 7 |
Antibacterial and Healing Potential of Zn-Al LDHs/Cellulose Acetate Nanocomposite in Burns and Wounds: A Study on Earthworms as a Human Skin Model |
2024 |
| 8 |
Azithromycin use before and during the COVID-19 pandemic and the impact of implementing national evidence-based guidelines in Qatar |
2024 |
| 9 |
Design, synthesis, biological evaluation and docking study of some new aryl and heteroaryl thiomannosides as FimH antagonists. |
2024 |
| 10 |
Interferon-induced transmembrane protein 3 (IFITM3) gene polymorphisms in COVID-19 patients in Assiut University Hospitals |
2024 |